Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.

Antonio Sahuquillo-TorralbaMansilla-Polo MiguelConrad Pujol-MarcoMar Llamas-VelascoEva V RullRicardo Ruiz VillaverdeMarta FerranGerard PitarchAnna LopezEmma BeltranAna Urruticoechea-AranaJosep Riera-MonroigMerce AlsinaDavid VidalIsabel Belinchón-RomeroJaime NotarioY José Manuel Carrascosa Víctor A González-DelgadoJordi MolletMiquel RiberaFernando Gallardo

Published in: International journal of dermatology (2024)

Certolizumab consistently showed high effectiveness and drug survival rates in this real-life cohort. The safety demonstrated in clinical trials during pregnancy and lactation seems to be confirmed in clinical practice.

Keyphrases

clinical practice
clinical trial
randomized controlled trial
systematic review
free survival
physical activity
human milk
cross sectional
atopic dermatitis
dairy cows
open label
phase ii
drug induced
phase iii
preterm birth